Judge Finds Warner-Lambert Accupril Patent Enabled

Law360, New York (December 3, 2007, 12:00 AM EST) -- A federal judge has ruled that claims of the patent involved in a long-standing dispute between Warner-Lambert Co. and generic maker Teva Pharmaceuticals USA Inc. are enabled, rejecting Teva’s theory of invalidity.

Following a bench trial on the matter in May, Judge Dickinson R. Debevoise of the U.S. District Court for the District of New Jersey ruled Thursday that claims in Warner-Lambert’s U.S. Patent Number 4,743,450 were enabled, despite Teva’s arguments that the patent’s vast claims and lack of guidance resulted in a failure to meet...
To view the full article, register now.